Original Research
Published on 02 Feb 2023
Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
in Cancer Immunity and Immunotherapy
- 3,681 views
- 17 citations